China Botanic Pharmaceutical (CBPI) financial statements (2022 and earlier)

Company profile

Business Address 80 BROAD STREET
NEW YORK, NY 10004
State of Incorp.
Fiscal Year End October 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

1/31/2022
TTM
10/31/2021
10/31/2020
ASSETS
Current Assets
Noncurrent Assets
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Due to related parties7231 
Total current liabilities:7231 
Noncurrent Liabilities
Total liabilities:7231 
Stockholders' equity
Stockholders' equity attributable to parent(72)(31) 
Preferred stock11 
Common stock373737
Additional paid in capital 11,99811,705
Accumulated deficit(12,108)(12,067)(11,742)
Other additional capital11,998  
Total stockholders' equity:(72)(31) 

Income statement (P&L) ($ in thousands)

1/31/2022
TTM
10/31/2021
10/31/2020
Gross profit: (44) 
Operating expenses(360)(325) 
Other undisclosed operating income 44 
Operating loss:(360)(325) 
Net loss attributable to parent:(360)(325) 
Other undisclosed net income available to common stockholders, basic144650 
Net income (loss) available to common stockholders, diluted:(216)325 

Comprehensive Income ($ in thousands)

1/31/2022
TTM
10/31/2021
10/31/2020
Net loss:(360)(325) 
Comprehensive loss, net of tax, attributable to parent:(360)(325) 

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: